Published in Urol Oncol on September 10, 2013
Regulation of cancer metastasis by cell-free miRNAs. Biochim Biophys Acta (2014) 1.02
Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker. BMC Cancer (2015) 0.97
Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer. J Transl Med (2015) 0.92
Oncogenic micro-RNAs and Renal Cell Carcinoma. Front Oncol (2014) 0.92
Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology. Chin J Cancer Res (2016) 0.91
A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma. J Cancer Res Clin Oncol (2015) 0.90
A non-invasive miRNA based assay to detect bladder cancer in cell-free urine. Am J Transl Res (2015) 0.86
miR-155 and miR-484 Are Associated with Time to Progression in Metastatic Renal Cell Carcinoma Treated with Sunitinib. Biomed Res Int (2015) 0.84
MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer. Sci Rep (2014) 0.84
The utility of urine-circulating miRNAs for detection of prostate cancer. Br J Cancer (2016) 0.80
Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer. Oncotarget (2016) 0.79
MiR-126 regulates proliferation and invasion in the bladder cancer BLS cell line by targeting the PIK3R2-mediated PI3K/Akt signaling pathway. Onco Targets Ther (2016) 0.76
Urinary microRNA can be concentrated, dried on membranes and stored at room temperature in vacuum bags. PeerJ (2015) 0.75
miRNA in Prostate Cancer: New Prospects for Old Challenges. EJIFCC (2014) 0.75
Identification of circulating microRNA signatures for upper tract urothelial carcinoma detection. Mol Med Rep (2015) 0.75
Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases. Exp Biol Med (Maywood) (2016) 0.75
Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation. Clin Epigenetics (2016) 0.75
Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer. Oncotarget (2016) 0.75
MicroRNAs in urine are not biomarkers of multiple myeloma. J Negat Results Biomed (2015) 0.75
High PCA3 scores in urine correlate with poor-prognosis factors in prostate cancer patients. Int J Clin Exp Med (2015) 0.75
Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma. Biochem Med (Zagreb) (2017) 0.75
Urine miR-21-5p as a potential non-invasive biomarker for gastric cancer. Oncotarget (2017) 0.75
Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma. Biochem Med (Zagreb) (2017) 0.75